Psychometric Evaluation of the Activity Impairment in Migraine-Diary (AIM-D) Using Data From a Phase 3 (PROGRESS) Clinical Trial in Patients With Chronic Migraine (P8-12.008)
Pranav Gandhi(AbbVie (United States)), Jonathan Stokes(Adelphi Laboratory Center), Stuart Yarr, Richard Lipton(Albert Einstein College of Medicine), Diane Whalley(RTI Health Solutions), Lauren Nelson(RTI Health Solutions), David W. Dodick(New York Academy of Medicine)
Cited by 3
Related Papers
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
|Annals of Neurology|1999|890
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
|British Journal of Dermatology|2019|384
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
|Cephalalgia|2018|382